107 related articles for article (PubMed ID: 3138871)
1. Modified in vivo platelet retention test for evaluating primary haemostasis.
de la Cuadra JL; Jeanneret C; Furlan M
Acta Haematol; 1988; 80(2):103-9. PubMed ID: 3138871
[TBL] [Abstract][Full Text] [Related]
2. [A modified in vivo platelet retention test in the evaluation of primary hemostasis].
de la Cuadra JL; Jeanneret C; Furlan M; Beck EA
Schweiz Med Wochenschr; 1987 Nov; 117(46):1814-6. PubMed ID: 3423768
[TBL] [Abstract][Full Text] [Related]
3. The platelet-function analyzer (PFA-100) for evaluating primary hemostasis.
Franchini M
Hematology; 2005 Jun; 10(3):177-81. PubMed ID: 16019466
[TBL] [Abstract][Full Text] [Related]
4. PFA-100 system: a new method for assessment of platelet dysfunction.
Mammen EF; Comp PC; Gosselin R; Greenberg C; Hoots WK; Kessler CM; Larkin EC; Liles D; Nugent DJ
Semin Thromb Hemost; 1998; 24(2):195-202. PubMed ID: 9579642
[TBL] [Abstract][Full Text] [Related]
5. Impaired interaction (adhesion-aggregation) of platelets with the subendothelium in storage-pool disease and after aspirin ingestion. A comparison with von Willebrand's disease.
Weiss HJ; Tschopp TB; Baumgartner HR
N Engl J Med; 1975 Sep; 293(13):619-23. PubMed ID: 1080251
[TBL] [Abstract][Full Text] [Related]
6. The post-aspirin bleeding time: a screening test for evaluating haemostatic disorders.
Stuart MJ; Miller ML; Davey FR; Wolk JA
Br J Haematol; 1979 Dec; 43(4):649-59. PubMed ID: 316709
[TBL] [Abstract][Full Text] [Related]
7. The platelet function analyzer (PFA-100): an update on its clinical use.
Franchini M
Clin Lab; 2005; 51(7-8):367-72. PubMed ID: 16122146
[TBL] [Abstract][Full Text] [Related]
8. Platelet-type von Willebrand's disease.
Miller JL
Clin Lab Med; 1984 Jun; 4(2):319-31. PubMed ID: 6437734
[TBL] [Abstract][Full Text] [Related]
9. "Haemostasis time", a modified bleeding time test and its comparison with the Duke and Ivy/template bleeding times. II. Application in bleeding disorders.
Janzarik H; Heinrich D; Bödeker RH; Lasch HG
Blut; 1988 Sep; 57(3):111-6. PubMed ID: 3262003
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of desmopressin effect on primary haemostasis in pediatric patients with aspirin-like defect as hereditary thrombocytopathy.
Tauer JT; Gneuss A; Lohse JE; Jürgens T; Knöfler R
Klin Padiatr; 2011 May; 223(3):169-72. PubMed ID: 21509710
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the Clot Signature Analyzer as a hemostasis test in healthy volunteers exposed to low doses of aspirin.
Igawa T; Kornhauser R; Cilla DD; King JO; Kambayashi J
Clin Appl Thromb Hemost; 1999 Apr; 5(2):117-21. PubMed ID: 10725992
[TBL] [Abstract][Full Text] [Related]
12. Use of the PFA-100 in the assessment of primary, platelet-related hemostasis in a pediatric setting.
Rand ML; Carcao MD; Blanchette VS
Semin Thromb Hemost; 1998; 24(6):523-9. PubMed ID: 10066147
[TBL] [Abstract][Full Text] [Related]
13. Valproate-mediated disturbances of hemostasis: relationship to dose and plasma concentration.
Gidal B; Spencer N; Maly M; Pitterle M; Williams E; Collins M; Jones J
Neurology; 1994 Aug; 44(8):1418-22. PubMed ID: 8058141
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the buccal bleeding time and platelet glass bead retention as assays of hemostasis in the dog: the effects of acetylsalicylic acid, warfarin and von Willebrand factor deficiency.
Brassard JA; Meyers KM
Thromb Haemost; 1991 Feb; 65(2):191-5. PubMed ID: 2053106
[TBL] [Abstract][Full Text] [Related]
15. Defective ristocetin-induced platelet aggregation in von Willebrand's disease and its correction by factor VIII.
Weiss HJ; Rogers J; Brand H
J Clin Invest; 1973 Nov; 52(11):2697-707. PubMed ID: 4201262
[TBL] [Abstract][Full Text] [Related]
16. The effect of ionophore on platelet aggregation in von Willebrand's disease and in congenital afibrinogenemia. A comparison with ristocetin.
Girolami A; Fabris F; Marco L; Peruffo R
Acta Haematol; 1976; 56(3):151-9. PubMed ID: 826070
[TBL] [Abstract][Full Text] [Related]
17. [Adhesion and aggregation in the subendothelium: hereditary platelet function disorder].
Tschopp TB; Weiss HJ; Baumgartner HR
Schweiz Med Wochenschr; 1975 Nov; 105(47):1587-9. PubMed ID: 1082165
[TBL] [Abstract][Full Text] [Related]
18. Prolonged bleeding time in children and young adults with hemophilia.
Buchanan GR; Holtkamp CA
Pediatrics; 1980 Dec; 66(6):951-5. PubMed ID: 7454486
[TBL] [Abstract][Full Text] [Related]
19. Utility of the PFA-100 as a screening test of platelet function: an audit of haemostasis laboratories in Australia and New Zealand.
Favaloro EJ; Bonar R; Duncan E; Rodgers S; Marsden K;
Blood Coagul Fibrinolysis; 2007 Jul; 18(5):441-8. PubMed ID: 17581318
[TBL] [Abstract][Full Text] [Related]
20. [New in vitro analysis tested: bleeding time is still the best method for evaluation of primary hemostasis].
Ridefelt P; Egberg N; Hillarp A; Lethagen S; Tengborn L
Lakartidningen; 2001 Sep; 98(37):3922-4. PubMed ID: 11586831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
